ARCHIVES

House Appropriations For NCI Identical (So Far) To White House Request; Slight Increase for NIH

This article is from The Cancer Letter archive.

Vol. 14 No. 26 | June 24, 1988

Download PDF Visit The Full Archive

Related Articles

Lasofoxifene Reduced Breast Cancer Risk In Postmenopausal Osteoporotic Women

November 26, 2010

FDA Simplifies Reporting Of Adverse Events

June 18, 1993

In Brief: BMS Oncology Names New VP, Marketing; Hortobagyi Wins Freyer Medal; Prerez Honored

October 24, 1997

Biopsies Could Be Reduced By Computer-Aided-Detection

December 26, 2003

Cancer Society, Centers Explore Collaboration On Public Issued, Education, Information Activities

January 25, 1991

FDA Approves Evista for Breast Cancer Risk Reduction.

September 14, 2007